Skip to content
10-Q

Quarterly Report

Tabula Rasa HealthCare, Inc.

0001558370-22-016383

← back to feed
Filed
Nov 4, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 15, 2022 27.12M sh
Shares Diluted Q3 2022 · Sep 30, 2022 24.35M sh
Shares Diluted Q3 2022 · Sep 30, 2022 24.08M sh
Shares Diluted Q3 2022 · Sep 30, 2021 23.41M sh
Shares Diluted Q3 2022 · Sep 30, 2021 23.23M sh
Capex Q3 2022 · Sep 30, 2022 $1.02M
Capex Q3 2022 · Sep 30, 2021 $1.61M
Operating Cash Flow Q3 2022 · Sep 30, 2022 $9.75M
Operating Cash Flow Q3 2022 · Sep 30, 2021 $3.02M
Long Term Debt Q3 2022 · Sep 30, 2022 $320.3M
Long Term Debt Q3 2022 · Dec 31, 2021 $319.3M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $80.78M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $9.4M
Cash And Equivalents restated Q3 2022 · Sep 30, 2021 $10.76M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$31.65M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$6.68M
Stockholders Equity Q3 2022 · Mar 31, 2022 $36.23M
Stockholders Equity Q3 2022 · Dec 31, 2021 $55.76M
Stockholders Equity Q3 2022 · Sep 30, 2021 $67.25M
Stockholders Equity Q3 2022 · Jun 30, 2021 $75.78M
Stockholders Equity Q3 2022 · Mar 31, 2021 $83.62M
Stockholders Equity Q3 2022 · Dec 31, 2020 $168.53M
Current Liabilities Q3 2022 · Sep 30, 2022 $98.06M
Current Liabilities Q3 2022 · Dec 31, 2021 $73.92M
Total Liabilities Q3 2022 · Sep 30, 2022 $435.5M
Total Liabilities Q3 2022 · Dec 31, 2021 $443.66M
Current Assets Q3 2022 · Sep 30, 2022 $179.84M
Current Assets Q3 2022 · Dec 31, 2021 $89.9M
Total Assets Q3 2022 · Sep 30, 2022 $403.85M
Total Assets Q3 2022 · Dec 31, 2021 $499.42M
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.65
Eps Diluted Q3 2022 · Sep 30, 2022 −$4.90
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.73
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.48
Eps Basic Q3 2022 · Sep 30, 2022 −$1.65
Eps Basic Q3 2022 · Sep 30, 2022 −$4.90
Eps Basic Q3 2022 · Sep 30, 2021 −$0.73
Eps Basic Q3 2022 · Sep 30, 2021 −$2.48
Sga Expense Q3 2022 · Sep 30, 2022 $27.92M
Sga Expense Q3 2022 · Sep 30, 2022 $58.95M
Sga Expense restated Q3 2022 · Sep 30, 2021 $14.39M
Sga Expense restated Q3 2022 · Sep 30, 2021 $45.73M
Rd Expense Q3 2022 · Sep 30, 2022 $4.02M
Rd Expense Q3 2022 · Sep 30, 2022 $11.23M
Rd Expense restated Q3 2022 · Sep 30, 2021 $3.7M
Rd Expense restated Q3 2022 · Sep 30, 2021 $11.07M
Net Income Q3 2022 · Sep 30, 2022 −$40.07M
Net Income Q3 2022 · Sep 30, 2022 −$117.87M
Net Income Q3 2022 · Jun 30, 2022 −$49.61M
Net Income Q3 2022 · Mar 31, 2022 −$28.19M
Net Income Q3 2022 · Sep 30, 2021 −$17.11M
Net Income Q3 2022 · Sep 30, 2021 −$57.68M
Net Income Q3 2022 · Jun 30, 2021 −$21.08M
Net Income Q3 2022 · Mar 31, 2021 −$19.49M
Operating Income Q3 2022 · Sep 30, 2022 −$23.65M
Operating Income Q3 2022 · Sep 30, 2022 −$51.64M
Operating Income restated Q3 2022 · Sep 30, 2021 −$9.44M
Operating Income restated Q3 2022 · Sep 30, 2021 −$31.96M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $60.24M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $169.59M
Cost Of Revenue restated Q3 2022 · Sep 30, 2021 $51.22M
Cost Of Revenue restated Q3 2022 · Sep 30, 2021 $142.81M
Revenue Q3 2022 · Sep 30, 2022 $77.1M
Revenue Q3 2022 · Sep 30, 2022 $216.81M
Revenue restated Q3 2022 · Sep 30, 2021 $67.91M
Revenue restated Q3 2022 · Sep 30, 2021 $190.99M